Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Asthma phenotypes: the evolution from clinical to molecular approaches
SE Wenzel - Nature medicine, 2012 - nature.com
Although asthma has been considered as a single disease for years, recent studies have
increasingly focused on its heterogeneity. The characterization of this heterogeneity has …
increasingly focused on its heterogeneity. The characterization of this heterogeneity has …
Severe asthma: from characteristics to phenotypes to endotypes
S Wenzel - Clinical & Experimental Allergy, 2012 - Wiley Online Library
Asthma, and severe asthma, in particular, is increasingly recognized as a heterogeneous
disease. While traditional views of asthma have centered around a childhood onset disease …
disease. While traditional views of asthma have centered around a childhood onset disease …
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.
WJ Fokkens, VJ Lund, J Mullol, C Bachert, I Alobid… - Rhinology, 2012 - europepmc.org
The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of
similar evidence based position papers published in 2005 and 2007. The document …
similar evidence based position papers published in 2005 and 2007. The document …
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
G Jia, RW Erickson, DF Choy, S Mosesova… - Journal of Allergy and …, 2012 - Elsevier
BACKGROUND: Eosinophilic airway inflammation is heterogeneous in asthmatic patients.
We recently described a distinct subtype of asthma defined by the expression of genes …
We recently described a distinct subtype of asthma defined by the expression of genes …
Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease
WW Stevens, CJ Ocampo, S Berdnikovs… - American journal of …, 2015 - atsjournals.org
Rationale: The mechanisms that underlie the pathogenesis of chronic rhinosinusitis without
nasal polyps (CRSsNP), chronic rhinosinusitis with nasal polyps (CRSwNP), and aspirin …
nasal polyps (CRSsNP), chronic rhinosinusitis with nasal polyps (CRSwNP), and aspirin …
Periostin in allergy and inflammation
E Sonnenberg-Riethmacher, M Miehe… - Frontiers in …, 2021 - frontiersin.org
Matricellular proteins are involved in the crosstalk between cells and their environment and
thus play an important role in allergic and inflammatory reactions. Periostin, a matricellular …
thus play an important role in allergic and inflammatory reactions. Periostin, a matricellular …
Periostin in inflammation and allergy
K Izuhara, S Nunomura, Y Nanri, M Ogawa… - Cellular and Molecular …, 2017 - Springer
We found for the first time that IL-4 and IL-13, signature type 2 cytokines, are able to induce
periostin expression. We and others have subsequently shown that periostin is highly …
periostin expression. We and others have subsequently shown that periostin is highly …
Progress in understanding hypersensitivity reactions to nonsteroidal anti‐inflammatory drugs
I Doña, N Pérez‐Sánchez, I Eguiluz‐Gracia… - Allergy, 2020 - Wiley Online Library
Nonsteroidal anti‐inflammatory drugs (NSAIDs), the medications most commonly used for
treating pain and inflammation, are the main triggers of drug hypersensitivity reactions. The …
treating pain and inflammation, are the main triggers of drug hypersensitivity reactions. The …
Periostin: an emerging biomarker for allergic diseases
Periostin is a matricellular protein as well as an extracellular matrix (ECM) protein belonging
to the fasciclin family. Periostin plays important roles as a matricellular protein in the setting …
to the fasciclin family. Periostin plays important roles as a matricellular protein in the setting …
Genetics and epigenetics of chronic rhinosinusitis
Discerning the genetics and epigenetics of chronic rhinosinusitis (CRS) may optimize
outcomes through early diagnostics, personalized and novel therapeutics, and early …
outcomes through early diagnostics, personalized and novel therapeutics, and early …